Diseño de un péptido inhibidor de la interacción DBP-DARC En Plasmodium VIVAX
- Autores:
-
López Puentes, Daniel
Hernández Zambrano, Laura J
Garzón Ospina, Diego
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2026
- Institución:
- Universidad Pedagógica y Tecnológica de Colombia
- Repositorio:
- RiUPTC: Repositorio Institucional UPTC
- Idioma:
- spa
- OAI Identifier:
- oai:repositorio.uptc.edu.co:001/18853
- Acceso en línea:
- https://repositorio.uptc.edu.co/handle/001/18853
https://doi.org/10.19053/uptc.01217488.v16.n2E.2025.19956
- Palabra clave:
- Plasmodium vivax, inhibidor de péptidos, interacción DBP-DARC.
Plasmodium vivax, Peptide inhibitor, DBP-DARC interaction.
- Rights
- openAccess
- License
- https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
| id |
REPOUPTC2_c3528287fe18f13aac6cf99ade42eef2 |
|---|---|
| oai_identifier_str |
oai:repositorio.uptc.edu.co:001/18853 |
| network_acronym_str |
REPOUPTC2 |
| network_name_str |
RiUPTC: Repositorio Institucional UPTC |
| repository_id_str |
|
| dc.title.es-ES.fl_str_mv |
Diseño de un péptido inhibidor de la interacción DBP-DARC En Plasmodium VIVAX |
| title |
Diseño de un péptido inhibidor de la interacción DBP-DARC En Plasmodium VIVAX |
| spellingShingle |
Diseño de un péptido inhibidor de la interacción DBP-DARC En Plasmodium VIVAX Plasmodium vivax, inhibidor de péptidos, interacción DBP-DARC. Plasmodium vivax, Peptide inhibitor, DBP-DARC interaction. |
| title_short |
Diseño de un péptido inhibidor de la interacción DBP-DARC En Plasmodium VIVAX |
| title_full |
Diseño de un péptido inhibidor de la interacción DBP-DARC En Plasmodium VIVAX |
| title_fullStr |
Diseño de un péptido inhibidor de la interacción DBP-DARC En Plasmodium VIVAX |
| title_full_unstemmed |
Diseño de un péptido inhibidor de la interacción DBP-DARC En Plasmodium VIVAX |
| title_sort |
Diseño de un péptido inhibidor de la interacción DBP-DARC En Plasmodium VIVAX |
| dc.creator.fl_str_mv |
López Puentes, Daniel Hernández Zambrano, Laura J Garzón Ospina, Diego |
| dc.contributor.author.spa.fl_str_mv |
López Puentes, Daniel Hernández Zambrano, Laura J Garzón Ospina, Diego |
| dc.subject.none.fl_str_mv |
Plasmodium vivax, inhibidor de péptidos, interacción DBP-DARC. Plasmodium vivax, Peptide inhibitor, DBP-DARC interaction. |
| topic |
Plasmodium vivax, inhibidor de péptidos, interacción DBP-DARC. Plasmodium vivax, Peptide inhibitor, DBP-DARC interaction. |
| publishDate |
2026 |
| dc.date.accessioned.none.fl_str_mv |
2026-10-26 10:21:04 |
| dc.date.available.none.fl_str_mv |
2026-10-26 10:21:04 |
| dc.date.issued.none.fl_str_mv |
2026-10-26 |
| dc.type.spa.fl_str_mv |
Artículo de revista |
| dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
| dc.type.driver.spa.fl_str_mv |
info:eu-repo/semantics/article |
| dc.type.local.eng.fl_str_mv |
Journal article |
| dc.type.version.spa.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.content.spa.fl_str_mv |
Text |
| dc.type.coarversion.spa.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| format |
http://purl.org/coar/resource_type/c_6501 |
| status_str |
publishedVersion |
| dc.identifier.issn.none.fl_str_mv |
0121-7488 |
| dc.identifier.uri.none.fl_str_mv |
https://repositorio.uptc.edu.co/handle/001/18853 |
| dc.identifier.doi.none.fl_str_mv |
10.19053/uptc.01217488.v16.n2E.2025.19956 |
| dc.identifier.eissn.none.fl_str_mv |
2462-7658 |
| dc.identifier.url.none.fl_str_mv |
https://doi.org/10.19053/uptc.01217488.v16.n2E.2025.19956 |
| identifier_str_mv |
0121-7488 10.19053/uptc.01217488.v16.n2E.2025.19956 2462-7658 |
| url |
https://repositorio.uptc.edu.co/handle/001/18853 https://doi.org/10.19053/uptc.01217488.v16.n2E.2025.19956 |
| dc.language.iso.spa.fl_str_mv |
spa |
| language |
spa |
| dc.relation.references.spa.fl_str_mv |
A. R. Tobin, R. Crow, D. V. Urusova, J. C. Klima, N. H. Tolia, and E. Strauch, “Inhibition of a malaria host–pathogen interaction by a computationally designed inhibitor,” Protein Science, vol. 32, no. 1, pp. 1–12, Jan. 2023, doi: 10.1002/pro.4507. [2] R. Moskovitz et al., “Structural basis for DARC binding in reticulocyte invasion by Plasmodium vivax,” Nat Commun, vol. 14, no. 1, p. 3637, Jun. 2023, doi: 10.1038/s41467-023-39357-w. [3] M. Yasir et al., “Computational Exploration of Licorice for Lead Compounds against Plasmodium vivax Duffy Binding Protein Utilizing Molecular Docking and Molecular Dynamic Simulation,” Molecules, vol. 28, no. 8, p. 3358, Apr. 2023, doi: 10.3390/molecules28083358. [4] M. Yasir et al., “Virtual Screening of Flavonoids against Plasmodium vivax Duffy Binding Protein Utilizing Molecular Docking and Molecular Dynamic Simulation,” Curr Comput Aided Drug Des, vol. 20, no. 5, pp. 616–627, Oct. 2024, doi: 10.2174/1573409919666230626140339. [5] M. S. Saddala and P. J. Adi, “Discovery of small molecules through pharmacophore modeling, docking and molecular dynamics simulation against Plasmodium vivax Vivapain-3 (VP-3),” Heliyon, vol. 4, no. 5, p. e00612, May 2018, doi: 10.1016/j.heliyon.2018.e00612. [6] M. Sivaramakrishnan, K. Kandaswamy, S. Natesan, R. D. Devarajan, S. G. Ramakrishnan, and R. Kothandan, “Molecular docking and dynamics studies on plasmepsin V of malarial parasite Plasmodium vivax,” Inform Med Unlocked, vol. 19, p. 100331, 2020, doi: 10.1016/j.imu.2020.100331. [7] P. Agrawal, H. Singh, H. K. Srivastava, S. Singh, G. Kishore, and G. P. S. Raghava, “Benchmarking of different molecular docking methods for protein-peptide docking,” BMC Bioinformatics, vol. 19, no. S13, p. 426, Feb. 2019, doi: 10.1186/s12859-018-2449-y. [8] R. Ochoa, Á. Santiago, and M. Alegría-Arcos, “Open protocols for docking and MD-based scoring of peptide substrates,” Artificial Intelligence in the Life Sciences, vol. 2, p. 100044, Dec. 2022, doi: 10.1016/j.ailsci.2022.100044. [9] X. Chen et al., “Protenix - Advancing Structure Prediction Through a Comprehensive AlphaFold3 Reproduction,” Jan. 11, 2025. doi: 10.1101/2025.01.08.631967. [10] J. Abramson et al., “Accurate structure prediction of biomolecular interactions with AlphaFold 3,” Nature, vol. 630, no. 8016, pp. 493–500, Jun. 2024, doi: 10.1038/s41586-024-07487-w. [11] A. Biswas, A. Narayan, S. Sinha, and K. Mandal, “Chemically Engineered Peptide Efficiently Blocks Malaria Parasite Entry into Red Blood Cells,” Biochemistry, vol. 64, no. 7, pp. 1501–1508, Apr. 2025, doi: 10.1021/acs.biochem.4c00465. [12] H. Yan, J. Feng, and M. Chen, “Structural Modelling Prediction of Recombinant Plasmodium falciparum K13-F446I and K13-C580Y Gene by AlphaFold Method and Heterologous Expression in Spodoptera frugiperda 9 Cells,” Pathogens, vol. 11, no. 11, Nov. 2022, doi: 10.3390/pathogens11111271. [13] T. H. Dickey and N. H. Tolia, “Designing an effective malaria vaccine targeting Plasmodium vivax Duffy-binding protein,” Trends Parasitol, vol. 39, no. 10, pp. 850–858, Oct. 2023, doi: 10.1016/j.pt.2023.06.011. [14] J. D. Batchelor, J. A. Zahm, and N. H. Tolia, “Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC,” Nat Struct Mol Biol, vol. 18, no. 8, pp. 908–914, Aug. 2011, doi: 10.1038/nsmb.2088. [15] J. D. Batchelor, B. M. Malpede, N. S. Omattage, G. T. DeKoster, K. A. Henzler-Wildman, and N. H. Tolia, “Red Blood Cell Invasion by Plasmodium vivax: Structural Basis for DBP Engagement of DARC,” PLoS Pathog, vol. 10, no. 1, Jan. 2014, doi: 10.1371/journal.ppat.1003869. [16] The Plasmodium Genome Database Collaborative, “PlasmoDB: An integrative database of the Plasmodium falciparum genome. Tools for accessing and analyzing finished and unfinished sequence data,” Nucleic Acids Res, vol. 29, no. 1, pp. 66–69, Jan. 2001, doi: 10.1093/nar/29.1.66. [17] A. Bateman et al., “UniProt: the Universal Protein Knowledgebase in 2025,” Nucleic Acids Res, vol. 53, no. D1, pp. D609–D617, Jan. 2025, doi: 10.1093/nar/gkae1010. [18] P. G. Magana Gomez and O. Kovalevskiy, “AlphaFold: A practical guide,” Mar. 06, 2024, Hinxton, UK. doi: 10.6019/TOL.AlphaFold-w.2024.00001.1. [19] Schrodinger LLC, “The PyMOL Molecular Graphics System, Version 3.1.3.1,” 2025. [Online]. Available: https://www.pymol.org/ [20] S. Saha et al., “Molecular mechanism of distinct chemokine engagement and functional divergence of the human Duffy antigen receptor,” Cell, vol. 187, no. 17, pp. 4751-4769.e25, 2024, doi: https://doi.org/10.1016/j.cell.2024.07.005. [21] E. Chen et al., “Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein,” Proceedings of the National Academy of Sciences, vol. 113, no. 22, pp. 6277–6282, 2016, doi: 10.1073/pnas.1600488113. [22] T. A. Rawlinson et al., “Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody,” Nat Microbiol, vol. 4, no. 9, pp. 1497–1507, Sep. 2019, doi: 10.1038/s41564-019-0462-1. [23] L. Sun, T. Fu, D. Zhao, H. Fan, and S. Zhong, “Divide-and-link peptide docking: a fragment-based peptide docking protocol,” Physical Chemistry Chemical Physics, vol. 23, no. 39, pp. 22647–22660, 2021, doi: 10.1039/D1CP02098F. [24] C. L. Gare et al., “Exploring the Utility of Cell‐Penetrating Peptides as Vehicles for the Delivery of Distinct Antimalarial Drug Cargoes,” ChemMedChem, vol. 20, no. 2, Jan. 2025, doi: 10.1002/cmdc.202400637. [25] M. Zalewski, B. Wallner, and S. Kmiecik, “Protein–Peptide Docking with ESMFold Language Model,” J Chem Theory Comput, vol. 21, no. 6, pp. 2817–2821, Mar. 2025, doi: 10.1021/acs.jctc.4c01585. |
| dc.relation.citationendpage.none.fl_str_mv |
22 |
| dc.relation.citationissue.spa.fl_str_mv |
2E |
| dc.relation.citationstartpage.none.fl_str_mv |
16 |
| dc.relation.citationvolume.spa.fl_str_mv |
16 |
| dc.relation.ispartofjournal.spa.fl_str_mv |
Ciencia en Desarrollo |
| dc.relation.bitstream.none.fl_str_mv |
https://revistas.uptc.edu.co/index.php/ciencia_en_desarrollo/article/download/19956/16068 |
| dc.relation.citationedition.spa.fl_str_mv |
Núm. 2E , Año 2025 : II Jornada de Investigación en Ciencias Biomédicas |
| dc.rights.uri.spa.fl_str_mv |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
| dc.rights.accessrights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
| dc.rights.coar.spa.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es http://purl.org/coar/access_right/c_abf2 |
| eu_rights_str_mv |
openAccess |
| dc.format.mimetype.spa.fl_str_mv |
application/pdf |
| dc.publisher.spa.fl_str_mv |
Universidad Pedagógica y Tecnológica de Colombia |
| dc.source.spa.fl_str_mv |
https://revistas.uptc.edu.co/index.php/ciencia_en_desarrollo/article/view/19956 |
| institution |
Universidad Pedagógica y Tecnológica de Colombia |
| bitstream.url.fl_str_mv |
https://repositorio.uptc.edu.co/bitstreams/fbacff53-fa68-4a41-90f8-dff8d3b97621/download |
| bitstream.checksum.fl_str_mv |
cbe09367425cda257d14411777360f82 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 |
| repository.name.fl_str_mv |
Repositorio Institucional UPTC |
| repository.mail.fl_str_mv |
bdigital@metabiblioteca.com |
| _version_ |
1881673976688672768 |
| spelling |
López Puentes, DanielHernández Zambrano, Laura JGarzón Ospina, Diego2026-10-26 10:21:042026-10-26 10:21:042026-10-260121-7488https://repositorio.uptc.edu.co/handle/001/1885310.19053/uptc.01217488.v16.n2E.2025.199562462-7658https://doi.org/10.19053/uptc.01217488.v16.n2E.2025.19956application/pdfspaUniversidad Pedagógica y Tecnológica de Colombiahttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.esinfo:eu-repo/semantics/openAccessEsta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.http://purl.org/coar/access_right/c_abf2https://revistas.uptc.edu.co/index.php/ciencia_en_desarrollo/article/view/19956Plasmodium vivax, inhibidor de péptidos, interacción DBP-DARC.Plasmodium vivax, Peptide inhibitor, DBP-DARC interaction.Diseño de un péptido inhibidor de la interacción DBP-DARC En Plasmodium VIVAXArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleJournal articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/coar/version/c_970fb48d4fbd8a85A. R. Tobin, R. Crow, D. V. Urusova, J. C. Klima, N. H. Tolia, and E. Strauch, “Inhibition of a malaria host–pathogen interaction by a computationally designed inhibitor,” Protein Science, vol. 32, no. 1, pp. 1–12, Jan. 2023, doi: 10.1002/pro.4507. [2] R. Moskovitz et al., “Structural basis for DARC binding in reticulocyte invasion by Plasmodium vivax,” Nat Commun, vol. 14, no. 1, p. 3637, Jun. 2023, doi: 10.1038/s41467-023-39357-w. [3] M. Yasir et al., “Computational Exploration of Licorice for Lead Compounds against Plasmodium vivax Duffy Binding Protein Utilizing Molecular Docking and Molecular Dynamic Simulation,” Molecules, vol. 28, no. 8, p. 3358, Apr. 2023, doi: 10.3390/molecules28083358. [4] M. Yasir et al., “Virtual Screening of Flavonoids against Plasmodium vivax Duffy Binding Protein Utilizing Molecular Docking and Molecular Dynamic Simulation,” Curr Comput Aided Drug Des, vol. 20, no. 5, pp. 616–627, Oct. 2024, doi: 10.2174/1573409919666230626140339. [5] M. S. Saddala and P. J. Adi, “Discovery of small molecules through pharmacophore modeling, docking and molecular dynamics simulation against Plasmodium vivax Vivapain-3 (VP-3),” Heliyon, vol. 4, no. 5, p. e00612, May 2018, doi: 10.1016/j.heliyon.2018.e00612. [6] M. Sivaramakrishnan, K. Kandaswamy, S. Natesan, R. D. Devarajan, S. G. Ramakrishnan, and R. Kothandan, “Molecular docking and dynamics studies on plasmepsin V of malarial parasite Plasmodium vivax,” Inform Med Unlocked, vol. 19, p. 100331, 2020, doi: 10.1016/j.imu.2020.100331. [7] P. Agrawal, H. Singh, H. K. Srivastava, S. Singh, G. Kishore, and G. P. S. Raghava, “Benchmarking of different molecular docking methods for protein-peptide docking,” BMC Bioinformatics, vol. 19, no. S13, p. 426, Feb. 2019, doi: 10.1186/s12859-018-2449-y. [8] R. Ochoa, Á. Santiago, and M. Alegría-Arcos, “Open protocols for docking and MD-based scoring of peptide substrates,” Artificial Intelligence in the Life Sciences, vol. 2, p. 100044, Dec. 2022, doi: 10.1016/j.ailsci.2022.100044. [9] X. Chen et al., “Protenix - Advancing Structure Prediction Through a Comprehensive AlphaFold3 Reproduction,” Jan. 11, 2025. doi: 10.1101/2025.01.08.631967. [10] J. Abramson et al., “Accurate structure prediction of biomolecular interactions with AlphaFold 3,” Nature, vol. 630, no. 8016, pp. 493–500, Jun. 2024, doi: 10.1038/s41586-024-07487-w. [11] A. Biswas, A. Narayan, S. Sinha, and K. Mandal, “Chemically Engineered Peptide Efficiently Blocks Malaria Parasite Entry into Red Blood Cells,” Biochemistry, vol. 64, no. 7, pp. 1501–1508, Apr. 2025, doi: 10.1021/acs.biochem.4c00465. [12] H. Yan, J. Feng, and M. Chen, “Structural Modelling Prediction of Recombinant Plasmodium falciparum K13-F446I and K13-C580Y Gene by AlphaFold Method and Heterologous Expression in Spodoptera frugiperda 9 Cells,” Pathogens, vol. 11, no. 11, Nov. 2022, doi: 10.3390/pathogens11111271. [13] T. H. Dickey and N. H. Tolia, “Designing an effective malaria vaccine targeting Plasmodium vivax Duffy-binding protein,” Trends Parasitol, vol. 39, no. 10, pp. 850–858, Oct. 2023, doi: 10.1016/j.pt.2023.06.011. [14] J. D. Batchelor, J. A. Zahm, and N. H. Tolia, “Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC,” Nat Struct Mol Biol, vol. 18, no. 8, pp. 908–914, Aug. 2011, doi: 10.1038/nsmb.2088. [15] J. D. Batchelor, B. M. Malpede, N. S. Omattage, G. T. DeKoster, K. A. Henzler-Wildman, and N. H. Tolia, “Red Blood Cell Invasion by Plasmodium vivax: Structural Basis for DBP Engagement of DARC,” PLoS Pathog, vol. 10, no. 1, Jan. 2014, doi: 10.1371/journal.ppat.1003869. [16] The Plasmodium Genome Database Collaborative, “PlasmoDB: An integrative database of the Plasmodium falciparum genome. Tools for accessing and analyzing finished and unfinished sequence data,” Nucleic Acids Res, vol. 29, no. 1, pp. 66–69, Jan. 2001, doi: 10.1093/nar/29.1.66. [17] A. Bateman et al., “UniProt: the Universal Protein Knowledgebase in 2025,” Nucleic Acids Res, vol. 53, no. D1, pp. D609–D617, Jan. 2025, doi: 10.1093/nar/gkae1010. [18] P. G. Magana Gomez and O. Kovalevskiy, “AlphaFold: A practical guide,” Mar. 06, 2024, Hinxton, UK. doi: 10.6019/TOL.AlphaFold-w.2024.00001.1. [19] Schrodinger LLC, “The PyMOL Molecular Graphics System, Version 3.1.3.1,” 2025. [Online]. Available: https://www.pymol.org/ [20] S. Saha et al., “Molecular mechanism of distinct chemokine engagement and functional divergence of the human Duffy antigen receptor,” Cell, vol. 187, no. 17, pp. 4751-4769.e25, 2024, doi: https://doi.org/10.1016/j.cell.2024.07.005. [21] E. Chen et al., “Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein,” Proceedings of the National Academy of Sciences, vol. 113, no. 22, pp. 6277–6282, 2016, doi: 10.1073/pnas.1600488113. [22] T. A. Rawlinson et al., “Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody,” Nat Microbiol, vol. 4, no. 9, pp. 1497–1507, Sep. 2019, doi: 10.1038/s41564-019-0462-1. [23] L. Sun, T. Fu, D. Zhao, H. Fan, and S. Zhong, “Divide-and-link peptide docking: a fragment-based peptide docking protocol,” Physical Chemistry Chemical Physics, vol. 23, no. 39, pp. 22647–22660, 2021, doi: 10.1039/D1CP02098F. [24] C. L. Gare et al., “Exploring the Utility of Cell‐Penetrating Peptides as Vehicles for the Delivery of Distinct Antimalarial Drug Cargoes,” ChemMedChem, vol. 20, no. 2, Jan. 2025, doi: 10.1002/cmdc.202400637. [25] M. Zalewski, B. Wallner, and S. Kmiecik, “Protein–Peptide Docking with ESMFold Language Model,” J Chem Theory Comput, vol. 21, no. 6, pp. 2817–2821, Mar. 2025, doi: 10.1021/acs.jctc.4c01585.222E1616Ciencia en Desarrollohttps://revistas.uptc.edu.co/index.php/ciencia_en_desarrollo/article/download/19956/16068Núm. 2E , Año 2025 : II Jornada de Investigación en Ciencias BiomédicasPublicationOREORE.xmltext/xml2715https://repositorio.uptc.edu.co/bitstreams/fbacff53-fa68-4a41-90f8-dff8d3b97621/downloadcbe09367425cda257d14411777360f82MD51falseAnonymousREAD001/18853oai:repositorio.uptc.edu.co:001/188532026-10-30 07:03:15.924https://creativecommons.org/licenses/by-nc-nd/4.0/deed.esmetadata.onlyhttps://repositorio.uptc.edu.coRepositorio Institucional UPTCbdigital@metabiblioteca.com |
